U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07315334) titled 'Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy' on Dec. 18, 2025.
Brief Summary: Chemotherapy-induced peripheral neuropathy (CIPN) is a severe side effect of several anti-cancer agents. Typical symptoms include tingling and hypoesthesia in the fingertips and/or toes, which substantially impair patients' quality of life and independence. Providing effective, evidence-based treatments for CIPN remains a major challenge in clinical practice. In a recent randomized clinical trial, our group demonstrated the effectiveness of electrotherapy in reducing both sensory and motor symptoms, as assess...